These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20217875)

  • 1. Sugar-based synthesis of Tamiflu and its inhibitory effects on cell secretion.
    Ma J; Zhao Y; Ng S; Zhang J; Zeng J; Than A; Chen P; Liu XW
    Chemistry; 2010 Apr; 16(15):4533-40. PubMed ID: 20217875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different synthetic strategies of oseltamivir phosphate: a potent influenza neuraminidase inhibitor.
    Gong J; Xu W
    Curr Med Chem; 2008; 15(30):3145-59. PubMed ID: 19075659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a concise synthesis of (-)-oseltamivir (Tamiflu).
    Trost BM; Zhang T
    Chemistry; 2011 Mar; 17(13):3630-43. PubMed ID: 21365707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroexcitatory actions of Tamiflu and its carboxylate metabolite.
    Izumi Y; Tokuda K; O'dell KA; Zorumski CF; Narahashi T
    Neurosci Lett; 2007 Oct; 426(1):54-8. PubMed ID: 17884292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-yielding synthesis of the anti-influenza neuramidase inhibitor (-)-oseltamivir by three "one-pot" operations.
    Ishikawa H; Suzuki T; Hayashi Y
    Angew Chem Int Ed Engl; 2009; 48(7):1304-7. PubMed ID: 19123206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.
    Shie JJ; Fang JM; Wang SY; Tsai KC; Cheng YS; Yang AS; Hsiao SC; Su CY; Wong CH
    J Am Chem Soc; 2007 Oct; 129(39):11892-3. PubMed ID: 17850083
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu) and active metabolite.
    Lindemann L; Jacobsen H; Schuhbauer D; Knoflach F; Gatti S; Wettstein JG; Loetscher H; Chu T; Ebeling M; Paulson JC; Prinssen E; Brockhaus M
    Eur J Pharmacol; 2010 Feb; 628(1-3):6-10. PubMed ID: 19917275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A concise and flexible synthesis of the potent anti-influenza agents tamiflu and tamiphosphor.
    Shie JJ; Fang JM; Wong CH
    Angew Chem Int Ed Engl; 2008; 47(31):5788-91. PubMed ID: 18613158
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereoisomers of oseltamivir - synthesis, in silico prediction and biological evaluation.
    Hajzer V; Fišera R; Latika A; Durmis J; Kollár J; Frecer V; Tučeková Z; Miertuš S; Kostolanský F; Varečková E; Šebesta R
    Org Biomol Chem; 2017 Feb; 15(8):1828-1841. PubMed ID: 28155963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamiflu: the supply problem.
    Farina V; Brown JD
    Angew Chem Int Ed Engl; 2006 Nov; 45(44):7330-4. PubMed ID: 17051628
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of oseltamivir phosphate (Tamiflu) and its metabolite (GS4071) on monoamine neurotransmission in the rat brain.
    Satoh K; Nonaka R; Ogata A; Nakae D; Uehara S
    Biol Pharm Bull; 2007 Sep; 30(9):1816-8. PubMed ID: 17827748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
    Magano J
    Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficient formal synthesis of oseltamivir phosphate (Tamiflu) with inexpensive D-ribose as the starting material.
    Osato H; Jones IL; Chen A; Chai CL
    Org Lett; 2010 Jan; 12(1):60-3. PubMed ID: 19938847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution and metabolism of the anti-influenza drug [11C]oseltamivir and its active metabolite [11C]Ro 64-0802 in mice.
    Hatori A; Arai T; Yanamoto K; Yamasaki T; Kawamura K; Yui J; Konno F; Nakao R; Suzuki K; Zhang MR
    Nucl Med Biol; 2009 Jan; 36(1):47-55. PubMed ID: 19181268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symmetry-based design for the chemoenzymatic synthesis of oseltamivir (Tamiflu) from ethyl benzoate.
    Sullivan B; Carrera I; Drouin M; Hudlicky T
    Angew Chem Int Ed Engl; 2009; 48(23):4229-31. PubMed ID: 19425033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of oseltamivir and tamiphosphor from N-acetyl-D-glucosamine.
    Chen CA; Fang JM
    Org Biomol Chem; 2013 Nov; 11(44):7687-99. PubMed ID: 24108094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors.
    Hong BT; Chen CL; Fang JM; Tsai KC; Wang SY; Huang WI; Cheng YE; Wong CH
    Bioorg Med Chem; 2014 Dec; 22(23):6647-6654. PubMed ID: 25456388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo synthesis of Tamiflu via a catalytic asymmetric ring-opening of meso-aziridines with TMSN3.
    Fukuta Y; Mita T; Fukuda N; Kanai M; Shibasaki M
    J Am Chem Soc; 2006 May; 128(19):6312-3. PubMed ID: 16683784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of electrolysis for inactivation of an antiviral drug that is one of possible selection pressure to drug-resistant influenza viruses.
    Kobayashi T; Hirose J; Wu H; Sano K; Katsumata T; Tsujibo H; Nakano T
    J Virol Methods; 2013 Dec; 194(1-2):154-60. PubMed ID: 23994466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular genetic studies of the susceptibility of epidemic influenza A(H1N1) virus strains isolated in the 2006-2009 seasons in Russia to oseltamivir (Tamiflu)].
    Beliakova NV; Al'khovskiĭ SV; Shevchenko ES; Prilipov AG; Abramov DD; Kolobukhina LV; Merkulova LN; Trushakova SV; Burtseva EI
    Vopr Virusol; 2010; 55(5):10-3. PubMed ID: 21260988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.